Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

Annals of Neurology

Volumn 52, Issue 1, 2002, Pages 54-61

  Arvin, Kara L ^a   Han, Byung H ^a   Du, Yansheng ^b   Lin, Sui Zhen ^c   Paul, Steven M ^b,c   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FRONTAL LOBE; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; BRAIN; CAROTID ARTERIES; CASPASE 3; CASPASES; HYPOXIA-ISCHEMIA, BRAIN; INJECTIONS, INTRAPERITONEAL; LIGATION; MINOCYCLINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036289498     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10242     Document Type: Article

References (70)

1. Experimental biology of cerebral hypoxia-ischemia: Relation to perinatal brain damage
2. Systematic review of therapy after hypoxicischaemic brain injury in the perinatal period
3. Novel treatments after experimental brain injury
4. MK-801 protects the neonatal brain from hypoxic-ischemic damage
5. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development
6. Prevention by magnesium of excitotoxic neuronal death in the developing brain: An animal model for clinical intervention studies
7. Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat
8. Hypoxic-ischemic injury in the neonatal rat brain: Effects of pre- and posttreatment with the glutamate release inhibitor BW 1003C87
9. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat
10. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury
11. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat
12. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats
13. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxicischemic injury in fetal lambs
14. Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats
15. NGF protects the neonatal brain against hypoxic-ischemic injury
16. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
17. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
18. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage
19. Brief post hypoxicischemic hypothermia markedly delays neonatal brain injury
20. Post-hypoxic cooling of neonatal rats provides protection against brain injury
21. The effect of prolonged modification of cerebral temperature on the outcome after hypoxic-ischaemic brain injury in the infant rat
22. Posthypoxic hypothermia in newborn piglets
23. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain
24. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs
25. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: Short-and long-term outcome
26. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
27. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
28. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction
29. Inhibition of autoimmune encephalomyelitis by a tetracycline
30. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
31. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
32. The influence of immaturity on hypoxic-ischemic brain damage in the rat
33. Two models for determining the mechanisms of damage and repair after hypoxic-ischemic injury in the developing rat brain
34. BNDF blocks caspase-3 activation in neonatal hypoxia-ischemia
35. Anoxic-ischemic encephalopathy in rats
36. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat
37. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury
38. Selective sparing of NADPH-diapharose neurons in neonatal hypoxia-ischemia
39. Effects of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: Choline acetyltransferase immunocytochemistry
40. Postischemic hyperglycemia is not protective to the neonatal rat brain
41. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil
42. Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxiaischaemia is related to the degree of high energy phosphate depletion during the insult
43. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxiaischemia in the neonatal rat
44. Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats
45. Cytokines and perinatal brain injury
46. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia
47. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis
48. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat
49. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
50. Poly(ADP-ribose) polymerase cleavage during apoptosis: When and where?
51. Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: Marker for neuronal apoptosis
52. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain
53. Calpain and caspase: Can you tell the difference?
54. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates
55. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia
56. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia
57. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
58. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
59. A novel mechanism of action of chemically modified tetracyclines: Inhibition of COX-2-mediated prostaglandin E2 production
60. Cerebral white matter damage in the preterm infant: Pathophysiology and risk factors
61. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia
62. Fetal exposure to an intraamniotic inflammation and the development of cerebral palsy at age of three years
63. Interferons and cerebral palsy
64. Neonatal cytokines and coagulation factors in children with cerebral palsy
65. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia
66. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn
67. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy
68. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia